NCT00222482

Depakote ER in Borderline Personality Disorder

A Double-Blind and Placebo Controlled Assessment of Depakote ER in Borderline Personality Disorder

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (planned)
• Sponsor: University of Minnesota · Academic / Other
• Sex: All
• Age: 21 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

This study examines the effect of Depakote ER versus placebo in a randomized trial of borderline personality disorder. Patients all participate in DBT therapy and those who are not responsive are assigned to either Depakote ER or placebo for up to 12 weeks. Borderline Personality Symtoms are measured and side-effects are assessed.

Conditions

• Borderline Personality Disorder

Interventions

Type	Name	Description
DRUG	Depakote ER

Timeline

• Start date: 2003-03-01
• Completion: 2005-09-01
• First posted: 2005-09-22
• Last updated: 2007-08-09